We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

163 hedge funds and large institutions have $954M invested in MacroGenics in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,040% more call options, than puts

Call options by funds: $15.6M | Put options by funds: $1.37M

116% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 19

59% more capital invested

Capital invested by funds: $598M → $954M (+$355M)

15% more funds holding

Funds holding: 142 → 163 (+21)

10% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 50

3.55% more ownership

Funds ownership: 100.29% → 103.83% (+3.5%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
163
Holders Change
+21
Holders Change %
+14.79%
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
55
Reduced
50
Closed
19
Calls
$15.6M
Puts
$1.37M
Net Calls
+$14.2M
Net Calls Change
+$14M

Top Buyers

1
ACA
Avoro Capital Advisors
New York
+$93M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$36.4M
3
State Street
State Street
Massachusetts
+$33.5M
4
VPC
Vestal Point Capital
New York
+$11M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.83M

Top Sellers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$43.4M
2
AC
Armistice Capital
New York
-$32.8M
3
RCM
RA Capital Management
Massachusetts
-$29.8M
4
SCM
Silverarc Capital Management
Massachusetts
-$11.8M
5
Millennium Management
Millennium Management
New York
-$11.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Bellevue Group
Switzerland
$147M +$190K +12,549 +0.1%
ACA
2
Avoro Capital Advisors
New York
$90.5M +$93M +6,150,000 New
BlackRock
3
BlackRock
New York
$83.8M -$6.71M -444,155 -7%
State Street
4
State Street
Massachusetts
$64.6M +$33.5M +2,215,625 +102%
Vanguard Group
5
Vanguard Group
Pennsylvania
$54.1M -$9.55M -631,716 -15%
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$40.7M -$43.4M -2,872,960 -51%
FLSM
7
Frazier Life Sciences Management
California
$36.4M +$1.06M +70,000 +3%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$35.9M +$36.4M +2,409,237 +8,362%
AC
9
Armistice Capital
New York
$35.3M -$32.8M -2,172,000 -48%
RCM
10
RA Capital Management
Massachusetts
$30.6M -$29.8M -1,971,056 -49%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$21.1M +$422K +27,945 +2%
RSCM
12
Rock Springs Capital Management
Maryland
$19.2M +$1.91M +126,454 +11%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$15.5M -$2.47M -163,641 -13%
JP Morgan Chase
14
JP Morgan Chase
New York
$15.1M -$1.6M -105,695 -9%
WA
15
Wasatch Advisors
Utah
$14.6M -$4.66M -307,995 -24%
Northern Trust
16
Northern Trust
Illinois
$10.8M -$636K -42,065 -5%
VPC
17
Vestal Point Capital
New York
$10.7M +$11M +725,000 New
Renaissance Technologies
18
Renaissance Technologies
New York
$10.5M -$733K -48,500 -6%
PA
19
Pinnacle Associates
New York
$9.53M -$616K -40,745 -6%
N
20
Nuveen
North Carolina
$8.09M -$870K -57,571 -9%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$7.83M +$6.83M +451,700 +563%
Charles Schwab
22
Charles Schwab
California
$7.7M -$4.69M -310,554 -37%
IHAM
23
Integral Health Asset Management
New York
$7.36M +$756K +50,000 +11%
SCM
24
Silverarc Capital Management
Massachusetts
$7.04M -$11.8M -780,562 -62%
Acadian Asset Management
25
Acadian Asset Management
Massachusetts
$6.97M -$8.83M -584,280 -55%
1
2 3 4 5

MGNX Hedge Fund Activity: Q1 2024 in Review

163 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2024, worth a combined $954M — up 59% from $598M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new MGNX positions and 19 closed out — a net gain of 22 holders — while 55 added to existing stakes and 50 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $93M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $43.4M.

  • 163 institutional investors held MacroGenics (MGNX) as of Q1 2024, up from 142 in Q4 2023.
  • Funds reported $954M of MacroGenics stock for Q1 2024, up 59% quarter-over-quarter.
  • 41 funds opened new MacroGenics positions in Q1 2024 and 19 closed out, a net change of +22 holders.
  • The largest MacroGenics buyer in Q1 2024 was Avoro Capital Advisors, an estimated $93M added.
  • The largest MacroGenics seller in Q1 2024 was T. Rowe Price Investment Management, an estimated $43.4M sold.

Based on aggregated 13F filings for Q1 2024.